Submitted by Anonymous (not verified) on 30 August 2023 - 8:38
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing, Date of authorisation: 14/01/2015, Revision: 34, Status: Authorised
Source: